Altimmune (ALT) Other Working Capital Changes (2018 - 2020)
Altimmune (ALT) posted quarterly Other Working Capital Changes of -$18885.0 for Q1 2020, down 209.95% year-over-year from $17176.0 in Q2 2019, and down 151.23% quarter-over-quarter from $36865.0 in Q4 2019.
Altimmune (ALT) Other Working Capital Changes (2018 - 2020) Analysis & Trends
Altimmune (ALT) has reported Other Working Capital Changes for 3 consecutive years, with -$18885.0 the latest figure, recorded in Q1 2020.
- In Q1 2020, Other Working Capital Changes fell 209.95% year-over-year to -$18885.0; the TTM figure through Mar 2020 stood at -$14029.0 (up 38.11% YoY), while the FY2019 annual figure was $22032.0, up 211.39% from the prior year.
- Other Working Capital Changes retreated to -$18885.0 in Q1 2020 per ALT's latest filing, from $36865.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $1.8 million in Q2 2023 and bottomed at -$4.0 million in Q1 2024.
- Historically, Other Working Capital Changes has averaged -$437117.6 across 5 years, with a median of -$228000.0 in 2024.
- Annual changes were most pronounced in 2019 — Other Working Capital Changes soared 845.2% — and 2020, when it slumped 209.95%.
- Altimmune's Other Working Capital Changes stood at -$4947.0 in 2018, then jumped by 845.2% to $36865.0 in 2019, then plunged by 151.23% to -$18885.0 in 2020.
- Business Quant data shows ALT's Other Working Capital Changes at -$18885.0 in Q1 2020, $36865.0 in Q4 2019, and -$17635.0 in Q3 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Altimmune | 571.75 Mn | 571.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | -18,885.00 |
| Mar 31, 2020 | -18,885.00 |
| Mar 31, 2020 | -18,885.00 |
| Dec 31, 2019 | 36,865.00 |
| Dec 31, 2019 | 36,865.00 |
| Dec 31, 2019 | 36,865.00 |
| Sep 30, 2019 | -17,635.00 |
| Sep 30, 2019 | -17,635.00 |
| Sep 30, 2019 | -17,635.00 |
| Jun 30, 2019 | -14,374.00 |
| Jun 30, 2019 | -14,374.00 |
| Jun 30, 2019 | -14,374.00 |
| Mar 31, 2019 | 17,176.00 |
| Mar 31, 2019 | 17,176.00 |
| Mar 31, 2019 | 17,176.00 |
| Dec 31, 2018 | -4,947.00 |
| Dec 31, 2018 | -4,947.00 |
| Dec 31, 2018 | -4,947.00 |
| Sep 30, 2018 | -17,447.00 |
| Sep 30, 2018 | -17,447.00 |